A prediction-interval framework for identifying outlier control cohorts in lifespan studies
- 1The Jackson Laboratory
Abstract
Control cohorts anchor the interpretation of lifespan-extending interventions, yet their lifespans vary even under identical experimental conditions. Without quantifying this expected variation, it is difficult to distinguish unusually short- or long-lived cohorts arising by chance from those reflecting potential experimental anomalies, with important consequences for interpreting treatment effects. The National Institute on Aging Interventions Testing Program (ITP), which tests interventions in mice across three independent sites using standardized protocols, provides a unique opportunity to address this problem. Previously, unusually short-lived males at the University of Texas in 2017 and unusually long-lived females at The Jackson Laboratory in 2022 were identified as potentially anomalous, but no standardized framework existed to determine whether such deviations exceeded expected variation. Here, we analyzed 10,757 control mice spanning 18 years of the ITP to quantify historical variation within and between sites and develop a prediction-interval framework for prospectively identifying unusual cohorts. We found that year-to-year variation, particularly in males, contributed substantially more to variation among cohort means than expected from random sampling alone. Accounting for this variation, our predictive framework flagged the 2022 Jackson Laboratory females but not 2017 University of Texas males, while flagging a previously unrecognized male cohort. Excluding this newly flagged cohort from the original lifespan analysis changed the statistical significance of two rapamycin regimens. These findings highlight the importance of a standardized framework for outlier detection and demonstrate the importance of accounting for natural variability in aging studies.
Related
- Brain age prediction from structural and functional connectivity across the lifespan using connectome-based predictive modeling
- Perceived temporal acceleration across the lifespan: An integrative framework of mathematical, neurocognitive, emotional, and behavioral mechanisms
- An Interpretable Framework for Identifying EEG Spectral Biomarkers of Pathological Brain Aging.
- UcTCRp: a TCRβ-based framework for identifying and profiling MAIT- and iNKT-associated repertoire signals.
- PDI-Spot: A Robust Representation Learning Framework for Identifying Energetic Hotspots in Protein–DNA Complexes
BibTeX
@misc{maeyens2026predictioninterval,
title = {{A prediction-interval framework for identifying outlier control cohorts in lifespan studies}},
author = {L. T. Maeyens and A. Luciano and J. F. Nelson and G. A. Churchill},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.21.760720},
url = {https://www.biorxiv.org/content/10.64898/2026.10.21.760720v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - A prediction-interval framework for identifying outlier control cohorts in lifespan studies
AU - L. T. Maeyens
AU - A. Luciano
AU - J. F. Nelson
AU - G. A. Churchill
PY - 2026
DA - 2026/10/21
PB - bioRxiv
DO - 10.64898/2026.10.21.760720
UR - https://www.biorxiv.org/content/10.64898/2026.10.21.760720v1
AB - Control cohorts anchor the interpretation of lifespan-extending interventions, yet their lifespans vary even under identical experimental conditions. Without quantifying this expected variation, it is difficult to distinguish unusually short- or long-lived cohorts arising by chance from those reflecting potential experimental anomalies, with important consequences for interpreting treatment effects. The National Institute on Aging Interventions Testing Program (ITP), which tests interventions in mice across three independent sites using standardized protocols, provides a unique opportunity to address this problem. Previously, unusually short-lived males at the University of Texas in 2017 and unusually long-lived females at The Jackson Laboratory in 2022 were identified as potentially anomalous, but no standardized framework existed to determine whether such deviations exceeded expected variation. Here, we analyzed 10,757 control mice spanning 18 years of the ITP to quantify historical variation within and between sites and develop a prediction-interval framework for prospectively identifying unusual cohorts. We found that year-to-year variation, particularly in males, contributed substantially more to variation among cohort means than expected from random sampling alone. Accounting for this variation, our predictive framework flagged the 2022 Jackson Laboratory females but not 2017 University of Texas males, while flagging a previously unrecognized male cohort. Excluding this newly flagged cohort from the original lifespan analysis changed the statistical significance of two rapamycin regimens. These findings highlight the importance of a standardized framework for outlier detection and demonstrate the importance of accounting for natural variability in aging studies.
ER -